Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Epidemiology and risk factors for (tardive) dyskinesia.

International review of neurobiology - 1 Jan 2011

Tenback Diederik E, van Harten Peter N

Abstract excerpt

Dyskinesia can develop in patients with schizophrenia in the course of the disease with or without the use of antipsychotics.In patients with psychiatric disorders other than schizophrenia Tardive Dyskinesia (TD) can develop in patients treated with antipsychotics or other drugs with dopamine D2...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Catechol O-Methyltransferase
Share to Cytochrome P-450 CYP1A2
Share to Cytochrome P-450 CYP2D6

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Movement Disorders

Share to Polymorphism, Single Nucleotide

Share to Receptors, Dopamine

Share to Risk Factors

Share to Superoxide Dismutase

Source

Identifiers

PMID: 21907089
DOI: 10.1016/B978-0-12-381328-2.00009-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Prepared record publication-21907089-2026-09-05.1. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Epidemiology and risk factors for (tardive) dyskinesia.PMID 21907089Read ↗

Genetic underpinnings of tardive dyskinesia: passing the baton to pharmacogenetics.Semantic proximity Read ↗

Pharmacogenetics of tardive dyskinesia: an updated review of the literature.Semantic proximity Read ↗

Genetics of tardive dyskinesia: a review of progress over the past decade.Semantic proximity Read ↗

Genetic Factors Associated With Tardive Dyskinesia: From Pre-clinical Models to Clinical StudiesSemantic proximity Read ↗

Genetic susceptibility to tardive dyskinesia in chronic schizophrenia subjects: III. Lack of association of CYP3A4 and CYP2D6 gene polymorphisms.Semantic proximity Read ↗

Tardive Dyskinesia Development, Superoxide Dismutase Levels, and Relevant Genetic PolymorphismsSemantic proximity Read ↗

Association study of tardive dyskinesia and five DRD4 polymorphisms in schizophrenia patientsSemantic proximity Read ↗

Genetic susceptibility to Tardive Dyskinesia in chronic schizophrenia subjects: V. Association of CYP1A2 1545 C>T polymorphism.Semantic proximity Read ↗

Analysis of genetic variations in the dopamine D1 receptor (DRD1) gene and antipsychotics-induced tardive dyskinesia in schizophrenia.Semantic proximity Read ↗

Genetics of tardive dyskinesia.Semantic proximity Read ↗

Genetic susceptibility to tardive dyskinesia among schizophrenia subjects: IV. Role of dopaminergic pathway gene polymorphisms.Semantic proximity Read ↗

Candidate Genes Encoding Dopamine Receptors as Predictors of the Risk of Antipsychotic-Induced Parkinsonism and Tardive Dyskinesia in Schizophrenic PatientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.